As previously shown, nervus vagus stimulation can benefit COVID-19-associated hyperinflammation, thus, via platelet α7nAChR it might decrease coagulation and thrombotic process together with decreased inflammatory factors (which additionally activate platelets) and benefit COVID-19 patients. The gene discussed is CHRNA7; the disease is COVID-19.